X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (535) 535
Publication (70) 70
Book Chapter (19) 19
Book / eBook (8) 8
Book Review (4) 4
Web Resource (3) 3
Paper (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (274) 274
index medicus (193) 193
hematology (158) 158
male (132) 132
female (131) 131
oncology (130) 130
middle aged (115) 115
aged (109) 109
adult (99) 99
lymphomas (82) 82
prognosis (76) 76
b-cell lymphoma (72) 72
aged, 80 and over (62) 62
lymphoma (61) 61
non-hodgkins-lymphoma (61) 61
treatment outcome (58) 58
antineoplastic combined chemotherapy protocols - therapeutic use (57) 57
cancer (51) 51
chemotherapy (48) 48
rituximab (48) 48
disease-free survival (34) 34
survival (29) 29
lymphoma, large b-cell, diffuse - drug therapy (28) 28
lymphoma, b-cell, marginal zone - pathology (27) 27
neoplasm staging (27) 27
retrospective studies (26) 26
tissue lymphoma (26) 26
young adult (26) 26
analysis (24) 24
antineoplastic agents - therapeutic use (23) 23
lymphoma, b-cell, marginal zone - genetics (23) 23
therapy (23) 23
adolescent (22) 22
helicobacter pylori (22) 22
lymphoma, large b-cell, diffuse - genetics (22) 22
combined modality therapy (21) 21
kaplan-meier estimate (21) 21
lymphoma, large b-cell, diffuse - pathology (21) 21
patients (21) 21
survival analysis (21) 21
chronic lymphocytic-leukemia (20) 20
health aspects (20) 20
genetic aspects (19) 19
lymphoma, b-cell, marginal zone - therapy (19) 19
mantle cell lymphoma (19) 19
non-hodgkin-lymphoma (19) 19
diagnosis (18) 18
disease progression (18) 18
follicular lymphoma (18) 18
malt lymphoma (18) 18
anti-bacterial agents - therapeutic use (17) 17
care and treatment (17) 17
lymphoma, b-cell, marginal zone - drug therapy (17) 17
malignant-lymphoma (17) 17
marginal zone lymphoma (17) 17
mutation (17) 17
risk factors (17) 17
abridged index medicus (16) 16
disease (16) 16
expression (16) 16
follow-up studies (16) 16
hematology, oncology and palliative medicine (16) 16
hemic and lymphatic diseases (16) 16
leukemia, lymphocytic, chronic, b-cell - genetics (16) 16
lymphoma, b-cell, marginal zone - microbiology (16) 16
animals (15) 15
classification (15) 15
diffuse large b-cell lymphoma (15) 15
doxorubicin - administration & dosage (15) 15
gene expression profiling (15) 15
genomics (15) 15
lymphoma, non-hodgkin - pathology (15) 15
radiotherapy (15) 15
survival rate (15) 15
antineoplastic combined chemotherapy protocols - adverse effects (14) 14
chromosome aberrations (14) 14
drug administration schedule (14) 14
genes (14) 14
lymphoma - therapy (14) 14
non-hodgkin's lymphomas (14) 14
time factors (14) 14
antineoplastic combined chemotherapy protocols - administration & dosage (13) 13
cell line, tumor (13) 13
follow-up (13) 13
helicobacter infections - drug therapy (13) 13
helicobacter-pylori infection (13) 13
lymphoma - pathology (13) 13
lymphoma, b-cell - genetics (13) 13
lymphoma, non-hodgkin - therapy (13) 13
malt (13) 13
pathology (13) 13
proportional hazards models (13) 13
prospective studies (13) 13
recurrence (13) 13
remission induction (13) 13
transplantation (13) 13
cyclophosphamide - administration & dosage (12) 12
fluorodeoxyglucose f18 (12) 12
high-dose chemotherapy (12) 12
immunoglobulin heavy chains - genetics (12) 12
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 09/2019, Volume 19, pp. S97 - S99
Journal Article
Blood, ISSN 0006-4971, 04/2016, Volume 127, Issue 17, pp. 2082 - 2092
Journal Article
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 09/2018, Volume 18, pp. S93 - S94
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9700, pp. 1512 - 1520
Summary Background Chemotherapy with high-dose methotrexate is the conventional approach to treat primary CNS lymphomas, but superiority of polychemotherapy... 
Internal Medicine | DEFERRED RADIOTHERAPY | MEDICINE, GENERAL & INTERNAL | B-CELL LYMPHOMA | INTERNATIONAL WORKSHOP | RESPONSE CRITERIA | EUROPEAN ORGANIZATION | CONSOLIDATING RADIOTHERAPY | NON-HODGKINS-LYMPHOMA | INITIAL TREATMENT | CENTRAL-NERVOUS-SYSTEM | CEREBROSPINAL-FLUID | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Lymphoma, Non-Hodgkin - radiotherapy | Cranial Irradiation - methods | Central Nervous System Neoplasms - radiotherapy | Adult | Lymphoma, Non-Hodgkin - drug therapy | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | Combined Modality Therapy | Remission Induction | Methotrexate - adverse effects | Antimetabolites, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Aged | Lymphoma, Non-Hodgkin - mortality | Central Nervous System Neoplasms - drug therapy | Central Nervous System Neoplasms - mortality | Cytarabine | Patient outcomes | Central nervous system diseases | Dosage and administration | Lymphomas | Drug therapy, Combination | Methotrexate | Drug therapy | Data analysis | Disease | Monoclonal antibodies | Data collection | Radiation therapy | Patients | Tropical diseases | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2014, Volume 32, Issue 27, pp. 3059 - 3067
Journal Article
European Journal of Internal Medicine, ISSN 0953-6205, 12/2018, Volume 58, p. 1
Journal Article
European Journal of Internal Medicine, ISSN 0953-6205, 12/2018, Volume 58, pp. 1 - 1
Journal Article
European Journal of Internal Medicine, ISSN 0953-6205, 12/2018, Volume 58, p. 1
Journal Article